Healthcare Capital Corp.
Status: Deal Closed
U=S+W/2
W=S@11.5
| IPO Proceeds, $M | $275.00M |
|---|---|
| IPO Date | Jan 15, 2021 |
| CEO | William Johns |
| Left Lead | Cantor Fitzgerald |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 months |
| IPO Sector |
Healthcare
Healthcare, with a focus on digital and telehealth, life sciences, innovative medical devices, and healthcare technology |
| IPO Geography | Global |
| Target Company | Alpha Tau |
| Deal Announced | Jul 8, 2021 |
| Deal Size, $M | $660.00M |
| Deal Sector | Healthcare |
| Deal Geography | Global |
| SEC Filings | www.sec.gov |
| Approval Vote | Feb 18, 2022 |
| Amendment Vote | TBD |
| Closing Date | Mar 7, 2022 |
Formerly HCCC
DRTS
DRTSW
| Price | $2.30 |
|---|---|
| Last closing price | $2.30 |
| H/L, today | $2.27 / $2.32 |
| H/L, 52-week | $2.75 / $5.95 |
| Volume, today | 13,220 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Healthcare Capital Corp.:
- Structure and cap table
- 13 directors & officers
- 25 filings and events
- 1 underwriters
- 6 deal advisors
- 4 legal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Dr. David Milch | 66 | Chairman |
| William Johns | 62 | CEO and Director |
| Philip A. Baseil | 64 | CFO |
| Dr. Thomas Insel | 68 | Director |
| Peter Kash | 59 | Director |
| Bruce E. Roberts | 55 | Director |
| Ambassador Ido Aharoni | Advisor | |
| Dr. Jacob Dagan | Advisor | |
| Yair Ephrati | Advisor | |
| Dr. Jacob A. Frenkel | Advisor | |
| Dr. David Levy | Advisor | |
| Dr. Steve Miller | Advisor | |
| Edward Neugeboren | Advisor |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
| Cantor Fitzgerald | BR | 24,000,000 | units |
| 24,000,000 | units | ||
| Up-Front UW fee | 2.00 | % | |
| Deferred UW fee |
3.50 | % |
Sign in to view more advisor data.
Deal
Sign in to view merger details and deal financials.